Artificial Intelligence | Machine Learning Dyno Therapeutics | Reshaping Gene Therapy with AI-Powered Vectors
Enterprise, Biotechnology, Healthcare, Data Science, Gene Therapy, Genome Editing Cambridge, MA, United States
Artificial Intelligence | Machine Learning
Dyno Therapeutics | Reshaping Gene Therapy with AI-Powered Vectors
Biotechnology, Healthcare, Data Science, Gene Therapy, Genome Editing
Cambridge, MA, 197
Dyno Therapeutics is pioneering artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeting capsid proteins from adeno-associated virus (AAV), the most widely-used vector for gene therapies. Our team includes world-class molecular and synthetic biologists, protein engineers, and gene therapy scientists working alongside software engineers, data scientists, and AI and machine learning experts. As we create AI-powered gene therapies that enhance the life-changing potential of gene therapies for millions of patients, we believe the future is within reach.
Gene vectors are the key to enabling gene therapies to reach a wider range of diseases and patients. Success in gene therapy relies on the vector’s ability to safely and precisely deliver a gene payload to the intended target cells and tissues. The efficacy of gene therapies, however, is currently limited by the roster of naturally occurring vectors, which are not optimized for disease treatment.
51 to 100
Reduce Operational Cost
Health Care Systems
Health Care Systems
Principal/Sr. Scientist, Program Lead - Gene Therapy; AAV Engineering
Scientist/Sr. Scientist - Gene Therapy
Sr. Research Associate - Library Cloning; AAV Engineering
Research Associate - Tissue Analysis; AAV Engineering
Want to work at Dyno Therapeutics?
We can introduce you to the right person at Dyno Therapeutics
Company was founded 2018 and it took almost 3 years (May 2021) to raise first external round
Polaris Partners, Obvious Ventures, Lux Capital, KdT Ventures, GV, Casdin Capital, Andreessen Horowitz
Date : 05/06/2021
Round: Series A
$ Raised: $100M
Investors: Polaris Partners, Obvious Ventures, Lux Capital, KdT Ventures, GV, Casdin Capital, Andreessen Horowitz
Interested in researching Dyno Therapeutics?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Dyno Therapeutics
Interested in what they do or partnership?
Learn more about how they work